We are Antioxidant 1135 CAS:125643-61-0 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests
SPECIFICATIONS AND PHYSICAL CHARACTERISTICS
TEST | UNIT | SPECIFICATION |
APPEARANCE | COLORLESS OR LIGHT YELLOW LIQUID | |
ASSAY | % | 98.00MIN |
SOLUBILITY | CLEAR | |
WATER | % | 0.10MAX |
PRODUCT FEATURES AND APPLICATIONS
* Primary antioxidant for organic polymers
* Can be used in a wide range of polymers such as PVC, ABS, PE, Rubbers such as SBR, BR & NBR, synthetic fibers, waxes, fats, oils and lubricants.
* Sterically hindered phenol and a liquid at room temperature
* Effective, non-discoloring stabilizer that provides excellent long term stability
* Exhibits a synergistic effect in combination with phosphites.
* Can be used with benzotriazoles or HALS for thermal and light stabilization in outdoor applications.
PACKAGE
180KG DRUM
HANDLING AND STORAGE
Keep container tightly closed and dry and storage in cool place
Related News: Others — somewhat more cynically — wondered if this was a concerted effort to promote certain herbal products to boost their makers’ share prices ahead of the Chinese stock market’s re-opening Monday.N2-(cyclohexylmethyl)-N4-(3-fluoro-4-methoxyphenyl)-6-((1-methyl-1H-pyrrol-2-yl)methoxy)-1,3,5-triazine-2,4-diamine Matthew Cheung, Hong Kong’s No. 2 official, appealed to medical workers to reconsider. “At this critical moment, I believe the general public would count on medical personnel to fight against the epidemic together, in the spirit of professionalism,” he wrote in a blog post on Sunday.1-chloro-4-(diazomethyl)benzene In addition, due to the complex process of changing the API supplier and the risk of uncertainty, the viscosity of pharmaceutical and specialty API companies is usually better.phosphoric acid 2-dimethylamino-pyrimidin-4-yl ester diethyl ester Patents covering oral and injectable rigosertib have been issued in the US and are expected to provide coverage until at least 2037.Patents covering oral and injectable rigosertib have been issued in the US and are expected to provide coverage until at least 2037.
Product Name | |
---|---|
1-Ethoxy-1,1,2,3,3,3-hexafluoro-2-(trifluoromethyl)propane Cas:163702-06-5 | View Details |
ETHYLENE GLYCOL DIGLYCIDYL ETHER Cas:2224-15-9 | View Details |
2,4-Dithiapentane Cas:1618-26-4 | View Details |